Greater China Strategy | Alpha Picks: April Conviction Calls Chinese equities consolidated further in March amid outbreak of hostilities in the Middle East, with the HSI and MSCI China Index declining 6.9% mom and 7.5% mom respectively. We expect markets to stay volatile in April, though oversold rebounds are possible. We continue to focus on names with stronger fundamentals and remain buyers of tech names, adding Li Ning and Zijin Mining to our BUY list while taking profits on Ganfeng Lithium a...
Highlights On 8 Apr 26, Link REIT agreed to sell Swing By @ Thomson Plaza in Singapore for S$250m, implying a 45% profit margin on acquisition cost of S$172.5m and a premium to its latest book value. This deal leads to balance sheet enhancement and buyback potential, and also marks the start of LINK REIT’s capital recycling cycle. Maintain BUY with an unchanged target price of HK$42.60.
Company Update | Aeon Thana Sinsap (Thailand) (AEONTS TB/HOLD/Bt89.00/Target: Bt100.00) We came away from AEONTS’ analyst meeting with a neutral view. Management will tighten credit policy to preserve good asset quality in FY27. However, AEONTS intends to prevent three consecutive years of loan contraction by setting a double-digit loan growth target in FY27. The company set some buffers for the uncertainties from Middle East tensions, but we might see additional provisioning in FY27. Maintain H...
Company Update | Thai Union Group (TU TB/HOLD/Bt11.70/Target: Bt12.80) We expect TU to report a core profit at Bt804m, up 27% yoy, but down 13% qoq. Looking ahead, we remain cautious on the ambient business due to potential cost pressures. We expect price adjustments in the ambient segment to be insufficient to fully offset rising costs and could negatively impact volumes. Maintain HOLD, with a lower target price of Bt12.80.
Company Update | Delta (Thailand) (DELTA TB/HOLD/Bt284.00/Target: Bt280.00) We expect DELTA to report a 1Q26 net profit of Bt7.55b (+38% yoy, +4% qoq). 1Q is typically a softer quarter due to the long holiday period. We revised up our 2026-2028 earnings forecasts by 3%/6%/8% driven by stronger liquid cooling contribution in 2H26 and strong demand visibility in power supply over 2026-2028. Hence, we maintain HOLD with a higher target price of Bt280. DELTA’s valuation already reflects strong funda...
Company Update | Charoen Pokphand Foods (CPF TB/BUY/Bt20.80/Target: Bt25.00) CPF is expected to report core earnings of Bt3,108m, an increase from Bt178m in 4Q25, but down from Bt8,314m in 1Q25. We are positive on CPF, as earnings have been projected to continue improving qoq in 2Q26, supported by the positive momentum in livestock prices and the gradual stabilisation of China’s swine prices. We believe the negative news has been priced in. Upgrade to BUY; target price: Bt25.00.
Company Update | Bumrungrad Hospital (BH TB/BUY/Bt173.00/Target: Bt196.00) BH is expected to report 1Q26 net profit of Bt1.65b (-4.6% yoy, -12.3% qoq), pressured by the Middle East conflict disrupting patient flows. Revenue should fall to Bt5.9b, with margin pressure from fewer high-margin Middle East patients, partly offset by cost controls. The Middle East patients, contributing 22-24% of revenue exposure, drive a cut in 2026 forecasts. BIH Phuket opening is delayed to 2H27, easing cost pressu...
Top Stories Company Update | Bumrungrad Hospital (BH TB/BUY/Bt173.00/Target: Bt196.00) BH is expected to report 1Q26 net profit of Bt1.65b (-4.6% yoy, -12.3% qoq), pressured by the Middle East conflict disrupting patient flows. Revenue should fall to Bt5.9b, with margin pressure from fewer high-margin Middle East patients, partly offset by cost controls. The Middle East patients, contributing 22-24% of revenue exposure, drive a cut in 2026 forecasts. BIH Phuket opening is delayed to 2H27, easin...
Top Stories Company Update | Keppel DC REIT (KDCREIT SP/BUY/S$2.29/Target: S$2.82) In the near term, KDCREIT focuses on acquisitions from third-party vendors as potential acquisitions from its sponsor pipeline, such as SGP9 in Singapore and a data centre in Western Tokyo, would only be stabilised in 2028/29. FDCs are an interesting new asset class but do not fall within the ambit of permissible investments for S-REITs. Maintain BUY on resiliency of the data centre market in Singapore and support...
Negative Surprises Likely Out Of The Way Highlights We remain positive on PPB’s 2026 earnings outlook, driven by both its core businesses as well as Wilmar’s associate earnings. Agribusiness’ profitability is still expected to remain supported by a relatively stable cost base, whereas the film segment is likely to leverage on another robust line-up of movie releases this year. Maintain BUY with an unchanged SOTP-derived target price of RM14.10.
China banks generally delivered resilient revenue and earnings growth in 4Q25, supported by stabilising NII and accelerated fee income growth. SOE banks outperformed JSBs, driven by stronger other non-NII growth from profit-taking on AC and FVOCI bonds. Asset quality indicators were broadly stable, although retail asset quality risks remain elevated. Given the improving top-line growth and solid dividend yields, we upgrade the sector to OVERWEIGHT as a defensive play amid heightened geopolitical...
Top Stories Company Update | PPB Group (PEP MK/BUY/RM12.20/Target: RM14.10) Core businesses are expected to sustain their positive momentum, after charting a strong performance in 2025, particularly for its agribusiness and film operations. Agribusiness’ profitability is expected to remain supported by a relatively stable cost base, whereas PPB’s film segment would leverage on another solid line-up of movie releases for 2026. As for Wilmar, management expects no further impairment charges after ...
Top Stories Sector Update | Banking China banks generally delivered resilient revenue and earnings growth in 4Q25, supported by stabilising NII and accelerated fee income growth. SOE banks outperformed JSBs, driven by stronger other non-NII growth from profit-taking on AC and FVOCI bonds. Asset quality indicators were broadly stable, although retail asset quality risks remain elevated. Given the improving top-line growth and solid dividend yields, we upgrade the sector to OVERWEIGHT as a defens...
Company Update | Sarana Menara Nusantara (TOWR IJ/BUY/Rp496/Target: Rp620) We upgrade our call to BUY from HOLD with a target price of Rp620, revised from Rp600, based on 7.5x 2026 EV/EBITDA (-1.5SD to its five-year average). TOWR’s disciplined expansion, stable 2025 earnings, and strong balance sheet support its defensive profile. Near-term colocation growth faces pressure from industry consolidation, while improving tenancy quality, rising data traffic, and potential 5G/FWA rollout should supp...
Economics | Indonesia’s Foreign Reserves Hit Two-Year Low On Rupiah Defence Foreign reserves fell to US$148.2b (lowest since Jul 24), pushing the import coverage ratio below its historical average. This weakens rupiah defence, raises vulnerability to speculative attacks, and erodes confidence in BI’s forex intervention capacity. The rupiah sank to an all-time low of Rp17,100, pressured by a strong US dollar, Middle East tensions, rapid M2 growth, and widening fiscal and current account deficits....
Economics | Indonesia’s Foreign Reserves Hit Two-Year Low On Rupiah Defence Foreign reserves fell to US$148.2b (lowest since Jul 24), pushing the import coverage ratio below its historical average. This weakens rupiah defence, raises vulnerability to speculative attacks, and erodes confidence in BI’s forex intervention capacity. The rupiah sank to an all-time low of Rp17,100, pressured by a strong US dollar, Middle East tensions, rapid M2 growth, and widening fiscal and current account deficits....
Greater China Sector Update | Banking China banks generally delivered resilient revenue and earnings growth in 4Q25, supported by stabilising NII and accelerated fee income growth. SOE banks outperformed JSBs, driven by stronger other non-NII growth from profit-taking on AC and FVOCI bonds. Asset quality indicators were broadly stable, although retail asset quality risks remain elevated. Given the improving topline growth and solid dividend yields, we upgrade the sector to OVERWEIGHT as a de...
For the China market, we expect volume decline to narrow and ASP pressure to ease sequentially but EBITDA to fall more sharply than the top-line. For the South Korea market, we expect volume to remain under pressure but ASP to continue to benefit from the price hike, while EBITDA will face greater challenges. Budweiser APAC expects the new beer consumption tax to have no incremental impact, as it has already strictly adhered to this principle. Maintain BUY; target price: HK$9.90.
Most China healthcare companies under our coverage reported satisfactory 2025 results. Leading biopharmas, CRDMOs and internet healthcare players saw robust revenue and earnings expansion supported by rapid product sales growth and significant licence income contribution. We expect globalisation and improving operating efficiency to continue to drive rapid earnings growth for drug innovators and CRO leaders from 2026 onwards. Seeing strong online demand, internet healthcare players are likely to...
During the Ching Ming holiday (4-6 Apr 26), consumption-related sectors demonstrated a mild recovery trend. However, the introduction of the spring break, which overlapped with the Ching Ming holiday, boosted travel demand. Our preferred stocks include: Anta, CTG Duty-Free, Haidilao, Li Ning, Mengniu, Yili and Yum China. Maintain OVERWEIGHT
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.